TSS
MRKR icon

Two Sigma Securities’s Marker Therapeutics MRKR Stock Holding History

Two Sigma Securities’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9K Buy
+11,460
New +$18.2K ﹤0.01% 1420
2025
Q4 		– Sell
-47,603
Closed -$42.5K – 1820
2025
Q3 		$42.5K Buy
+47,603
New +$58.8K 0.01% 1010
2023
Q1 		– Sell
-1,873
Closed -$4.98K – 3049
2022
Q4 		$4.98K Buy
+1,873
New +$6.46K ﹤0.01% 2451

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Securities's MRKR Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Marker Therapeutics (MRKR) in Q1 2026: 11,460 shares worth $14.9K. The stake represents ﹤0.01% of the portfolio and ranks #1420 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in MRKR as recently as Q3 2025.

Two Sigma Securities first reported a position in MRKR in Q4 2022 and has held it in 3 quarters since. The position peaked at $42.5K in Q3 2025. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Two Sigma Securities held 11,460 shares of Marker Therapeutics worth $14.9K as of Q1 2026.
  • Marker Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • Marker Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1420 holding.
  • Two Sigma Securities first reported a position in Marker Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • Two Sigma Securities's Marker Therapeutics position peaked at $42.5K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.